Approximately 19 million U.S. women of childbearing age reside in what are known as “contraceptive deserts” due to geographic, political, economic and social barriers to birth control. Women living in ...

Researchers evaluated the association between the use of various hormonal contraceptives and the risk for surgically treated intracranial meningioma.

Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new study has found only about a quarter of reproductive health experts prescribe ...

Studies show Depo-Provera users have much higher relative risk of developing meningiomas, although overall risk remains low ...

Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new study has found only about a quarter of reproductive health experts prescribe ...

Women in America and the United Kingdom are taking legal action against Pfizer and other birth control producers after a study indicated that injectable contraceptives were found to cause brain tumors ...

Studies show that women who use a contraceptive injection known as Depo-Provera could increase their risk of benign brain tumours by as much as 500 per cent.

Guests and partners in the launch of private sector Depo Medroxy Progesterone Subcutaneous( DMPA- SC) contraceptive which is self-injected. [ Jenipher Wachie, Standard] Pharmacies will now serve as ...

Barrier and hormonal contraception methods only temporarily prevent pregnancy. Once a person stops using these methods, the body’s natural fertility will typically resume. Sterilization methods, such ...

Kenya's reproductive health services got a major boost after receiving 450,000 doses of self-injectable contraceptives. The Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) contraceptives, ...